The Johnson & Johnson vaccine has been criticized in the US. Is it good or not?

More than 50 million Americans have received at least one dose of the COVID-19 vaccine Pfizer The ModernSo far, great loyalty has been created towards these brands, but that the vaccine is about to change with the advent of Johnson & Johnson.

This new vaccine has since been classified as a turning point in vaccination efforts requires a single dose instead of applied two weeks apart. Moreover no need to freeze, making it a better option for rural communities or those who have limited access to health and storage facilities.

While some rave about the virtues, others have criticized this new alternative. Partly due to the uncertainty about its effectiveness and in another because on March 2 the Conference of Catholic Priests of the United States asked for the vaccine to be evaded Johnson & Johnson because It uses cells made in laboratories that are clones of fetal tissues from abortions performed in 1980.

If states don’t plan how each brand’s vaccines are distributed, the result can be a nightmare of frustrated patients and wasted vaccines.

Experts specializing in healthcare operations, data analysis and supply chain coordination from the source The conversation analyzed policies for the distribution of covid-19 vaccines in the United States. Their research shows there is a lot of potential in a single dose vaccine, but that You can criticize the Johnson & Johnson during planning and distribution decisions.

J&J Vaccine Efficacy Level

The main factor hindering acceptance of the Johnson & Johnson vaccine is that the efficiency level is only 66 percent, while that of Pfizer Y Modern have levels of at least 90 percent.

Comparing those figures is not that easy as the clinical studies were conducted at different times. That of Pfizer Y Modern were created before many of the new coronavirus variants were reported and those of NO WORD thereafter. Consequently Johnson & Johnson it has evidence that its vaccine works against the British, South African and Brazilian variants, while the other drugs do not.

In terms of prevention of serious illness, hospitalization and death, the vaccine NO WORD is similar to that of Pfizer Y Modern Given the shortage of vaccine supplies, it is best for patients to accept one of the three as soon as possible.

Obvious and worrisome rejection

According to a study conducted in January by the Centers for Disease Control and Prevention of the United States (CDC), by giving you the choice between the two-dose and two-dose vaccines NO WORD 60 percent of the participants said they preferred the former and only 7 percent said the latter.

Of those who preferred the former, 72 percent are willing to wait up to a month the single dose vaccine between doses to be administered.

Serious consequences

In the European Union it is 80 percent of vaccine doses are made by Astra Zeneca (which also has low efficacy and is not approved in the United States) is wasted because many people, including doctors, believe that it is inferior to that of Pfizer.

Strategies for Greater Adoption of the Johnson & Johnson Vaccine:

The conversation Suggests that health authorities take the following actions based on their investigation:

  1. Inform people which vaccine they will receive as soon as you make your appointment for the vaccination. This prevents vaccines from being rejected once at the sites and from wasting time and dose.
  2. Only use one type of vaccine at each site. This allows people to choose the location based on the vaccine they prefer and avoids last minute cancellations. It also helps to ease the application process and avoid handling errors.
  3. Offer people from rural areas, where it would be more convenient to use the NO WORD the ability to travel a reasonable distance to locations where vaccines are available Pfizer Y Modern so that they don’t feel compelled to consume the former. This would help reduce mistrust and allow people to make an informed choice.
  4. Be more transparent about the differences between the three vaccines and educate the public about the effectiveness of Johnson & Johnson. The focus should be on harnessing all vaccines to achieve herd immunity as soon as possible.

pmm

Source